Purple Biotech (PPBT) has released an update.
Purple Biotech Ltd. is incentivizing warrant holders with new warrants and a reduced exercise price for quick cash exercise of their existing warrants. This strategic move aims to stimulate investment by offering additional Series A-1 and Series A-2 warrants with a five-year and a two-year term respectively, both exercisable immediately at a price of $0.40 per ADS. The company is targeting accredited investors and entities, providing opportunities for investment growth through these newly issued warrants.
For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.
